Modeling and quantifying biochemical changes in C6 tumor gliomas by Fourier transform infrared imaging

Abdelilah Beljebbar1, Nadia Amharref, Antoine Lévèques

  • 1Unite MeDIAN, Universite de Reims Champagne-Ardenne, UMR CNRS 6237-MEDYC, IFR 53, UFR de Pharmacie, 51 Rue Cognacq-Jay, 51096 Reims Cedex, France. abdelilah.beljebbar@univ-reims.fr

Analytical Chemistry
|October 22, 2008
PubMed

Insights

Fourier-transform infrared (FT-IR) microspectroscopic imaging identified molecular changes in glioma tissues. This technique can differentiate tissue types and aid in glioma diagnosis and treatment strategies.

Area of Science:

  • Biomedical Optics
  • Molecular Spectroscopy
  • Neuro-oncology

Background:

  • Gliomas are primary brain tumors with diverse molecular profiles.
  • Accurate tissue characterization is crucial for diagnosis, grading, and treatment planning.
  • Fourier-transform infrared (FT-IR) microspectroscopic imaging offers label-free molecular analysis.

Purpose of the Study:

  • To investigate molecular alterations in glioma tissues using FT-IR microspectroscopic imaging (FT-IRM).
  • To develop a spectroscopic model for quantifying chemical changes in glioma.
  • To establish FT-IRM as a tool for glioma diagnosis and prognosis.

Main Methods:

  • FT-IR microspectroscopic imaging (FT-IRM) was employed to analyze normal, tumoral, peri-tumoral, and necrotic brain tissues.
  • Multivariate statistical analysis was used to discriminate between tissue types.
  • A spectroscopic model was developed using FT-IR spectra of brain constituents (lipids, DNA, proteins).

Main Results:

  • FT-IRM successfully differentiated normal, tumoral, peri-tumoral, and necrotic tissues.
  • Key molecular changes involved lipids, proteins, and nucleic acids, serving as spectroscopic markers.
  • Specific changes in cholesterol, phosphatidylethanolamine, phosphatidylcholine, galactocerebroside, DNA, and oleic acid were identified in relation to tumor status and location.

Conclusions:

  • FT-IRM can accurately assess the distribution and variation of molecular constituents in glioma.
  • The developed spectroscopic model quantifies chemical changes associated with glioma.
  • FT-IRM holds potential for enhancing diagnostic accuracy, grading, prognosis, and therapeutic monitoring of gliomas.

Related Concept Videos